Janus Henderson Investors US’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | $510M | Buy |
1,317,162
+486,119
| +58% | +$188M | 0.42% | 56 |
|
|
2016
Q4 | $305M | Buy |
831,043
+16,185
| +2% | +$5.94M | 0.26% | 105 |
|
|
2016
Q3 | $327M | Sell |
814,858
-118,542
| -13% | -$47.6M | 0.28% | 88 |
|
|
2016
Q2 | $326M | Sell |
933,400
-655,230
| -41% | -$229M | 0.28% | 83 |
|
|
2016
Q1 | $573M | Sell |
1,588,630
-350,715
| -18% | -$126M | 0.5% | 38 |
|
|
2015
Q4 | $1.05B | Sell |
1,939,345
-210,692
| -10% | -$114M | 0.9% | 16 |
|
|
2015
Q3 | $1B | Buy |
2,150,037
+160,589
| +8% | +$74.7M | 0.9% | 17 |
|
|
2015
Q2 | $1.01B | Buy |
1,989,448
+347,005
| +21% | +$177M | 0.83% | 20 |
|
|
2015
Q1 | $742M | Buy |
1,642,443
+1,420,299
| +639% | +$641M | 0.61% | 26 |
|
|
2014
Q4 | $91.1M | Buy |
222,144
+26,605
| +14% | +$10.9M | 0.08% | 323 |
|
|
2014
Q3 | $70.5M | Buy |
195,539
+26,329
| +16% | +$9.49M | 0.06% | 350 |
|
|
2014
Q2 | $47.8M | Sell |
169,210
-1,726
| -1% | -$488K | 0.04% | 422 |
|
|
2014
Q1 | $51.3M | Sell |
170,936
-35,770
| -17% | -$10.7M | 0.05% | 391 |
|
|
2013
Q4 | $56.9M | Sell |
206,706
-59,500
| -22% | -$16.4M | 0.05% | 374 |
|
|
2013
Q3 | $83.3M | Sell |
266,206
-112,745
| -30% | -$35.3M | 0.08% | 277 |
|
|
2013
Q2 | $85.2M | Buy |
+378,951
| New | +$85.2M | 0.09% | 264 |
|